Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Class A common stock, par value $0.00001 per share
-
Shares outstanding
-
114M
-
Number of holders
-
332
-
Total 13F shares, excl. options
-
77.9M
-
Shares change
-
+7.71M
-
Total reported value, excl. options
-
$15.2B
-
Value change
-
+$1.52B
-
Put/Call ratio
-
0.18
-
Number of buys
-
213
-
Number of sells
-
-112
-
Price
-
$195.82
Significant Holders of 10x Genomics, Inc. - Class A common stock, par value $0.00001 per share (TXG) as of Q2 2021
390 filings reported holding TXG - 10x Genomics, Inc. - Class A common stock, par value $0.00001 per share as of Q2 2021.
10x Genomics, Inc. - Class A common stock, par value $0.00001 per share (TXG) has 332 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 77.9M shares
of 114M outstanding shares and own 68.08% of the company stock.
Largest 10 shareholders include FMR LLC (7.9M shares), BlackRock Inc. (7.55M shares), VANGUARD GROUP INC (7.08M shares), BAILLIE GIFFORD & CO (5.03M shares), MORGAN STANLEY (4.33M shares), ARK Investment Management LLC (4.3M shares), 12 West Capital Management LP (1.92M shares), Meritech Capital Associates V L.L.C. (1.79M shares), Foresite Capital Management II, LLC (1.75M shares), and Sumitomo Mitsui Trust Holdings, Inc. (1.74M shares).
This table shows the top 332 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.